Literature DB >> 15494479

Mechanisms of soluble cytokine receptor generation.

Stewart J Levine1.   

Abstract

Soluble cytokine receptors regulate inflammatory and immune events by functioning as agonists or antagonists of cytokine signaling. As such, they act within complex receptor systems that include signaling receptors, nonsignaling decoy receptors, receptor-associated proteins, and soluble receptor antagonists. Soluble cytokine receptors can be generated by several mechanisms, which include proteolytic cleavage of receptor ectodomains, alternative splicing of mRNA transcripts, transcription of distinct genes that encode soluble cytokine-binding proteins, release of full-length receptors within the context of exosome-like vesicles, and cleavage of GPI-anchored receptors. Furthermore, the important role of soluble cytokine receptors in regulating host defense mechanisms is evidenced by viruses that encode soluble homologues of mammalian receptors and thereby evade innate host immune responses via the sequestration of essential cytokines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15494479     DOI: 10.4049/jimmunol.173.9.5343

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

1.  Inhibition of foam cell formation using a soluble CD68-Fc fusion protein.

Authors:  Karin Daub; Dorothea Siegel-Axel; Tanja Schönberger; Christoph Leder; Peter Seizer; Karin Müller; Martin Schaller; Sandra Penz; Dagmar Menzel; Berthold Büchele; Andreas Bültmann; Götz Münch; Stephan Lindemann; Thomas Simmet; Meinrad Gawaz
Journal:  J Mol Med (Berl)       Date:  2010-05-08       Impact factor: 4.599

2.  Soluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected women.

Authors:  Yamil Gerena; Richard L Skolasky; Joyce M Velez; Dianedis Toro-Nieves; Raul Mayo; Avindra Nath; Valerie Wojna
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

Review 3.  Corticotropin releasing hormone and the skin.

Authors:  Andrzej Slominski; Blazej Zbytek; Michal Zmijewski; Radomir M Slominski; Sobia Kauser; Jacobo Wortsman; Desmond J Tobin
Journal:  Front Biosci       Date:  2006-09-01

Review 4.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

5.  Matrix metalloproteinase 8 contributes to solubilization of IL-13 receptor alpha2 in vivo.

Authors:  Weiguo Chen; Yasuhiro Tabata; Aaron M Gibson; Michael O Daines; Manoj R Warrier; Marsha Wills-Karp; Gurjit K Khurana Hershey
Journal:  J Allergy Clin Immunol       Date:  2008-08-09       Impact factor: 10.793

Review 6.  Molecular mechanisms of soluble cytokine receptor generation.

Authors:  Stewart J Levine
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

7.  Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.

Authors:  Asish K Ghosh; Charla R Secreto; Traci R Knox; Wei Ding; Debabrata Mukhopadhyay; Neil E Kay
Journal:  Blood       Date:  2009-12-17       Impact factor: 22.113

8.  MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome.

Authors:  QiQi Zhou; Wiley W Souba; Carlo M Croce; G Nicholas Verne
Journal:  Gut       Date:  2009-12-01       Impact factor: 23.059

9.  Conditional inactivation of TACE by a Sox9 promoter leads to osteoporosis and increased granulopoiesis via dysregulation of IL-17 and G-CSF.

Authors:  Keisuke Horiuchi; Tokuhiro Kimura; Takeshi Miyamoto; Kana Miyamoto; Haruhiko Akiyama; Hironari Takaishi; Hideo Morioka; Takashi Nakamura; Yasunori Okada; Carl P Blobel; Yoshiaki Toyama
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

10.  Mycobacterium tuberculosis infection induces il12rb1 splicing to generate a novel IL-12Rbeta1 isoform that enhances DC migration.

Authors:  Richard T Robinson; Shabaana A Khader; Cynthia A Martino; Jeffrey J Fountain; Maria Teixeira-Coelho; John E Pearl; Stephen T Smiley; Gary M Winslow; David L Woodland; Michael J Walter; Jose R Conejo-Garcia; Ueli Gubler; Andrea M Cooper
Journal:  J Exp Med       Date:  2010-03-08       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.